1. Signaling Pathways
  2. GPCR/G Protein
  3. Chemerin Receptor

Chemerin Receptor (趋化素受体)

Chemerin Receptor

趋化素受体是能与趋化素特异性结合的一类膜受体,属于 G 蛋白偶联受体家族,归类为 Class A。目前趋化素受体主要有趋化素受体 1,也称为 ChemR23 或 CMKLR1 和趋化素受体 2 ,也称为 GPR1。趋化素与其受体结合后,可招募并激活免疫细胞,增强机体的固有免疫和适应性免疫反应。同时,也可以调节血管内皮细胞的功能,促进血管生成。趋化素受体也参与能量代谢和脂肪组织的调节。趋化素及其受体表达和功能的异常与肿瘤、炎症性疾病和肥胖、糖尿病等代谢性疾病密切相关[1][2]

Chemerin receptors are a type of membrane receptors that can specifically bind to chemerin and belong to the G-protein-coupled receptor family Class A. Currently, the main chemerin receptors include chemerin receptor 1, also known as ChemR23 or CMKLR1, and chemerin receptor 2, also known as GPR1. After chemerin binds to its receptor, it can recruit and activate immune cells, enhancing the body's innate and adaptive immune responses. At the same time, it can also regulate the functions of vascular endothelial cells and promote angiogenesis. Chemerin receptors are also involved in the regulation of energy metabolism and adipose tissue. Abnormalities in the expression and function of chemerin and its receptors are closely related to cancer, inflammatory diseases, and metabolic diseases such as obesity and diabetes[1][2].

Chemerin Receptor 相关产品 (8):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-138097
    α-NETA ≥98.0%
    α-NETA 是一种有效的,非竞争性的胆碱乙酰转移酶 (ChA) 抑制剂,IC50 为 9 μM。α-NETA 是一种有效的 ALDH1A1 (IC50=0.04 μM) 和趋化因子样受体 1 (CMKLR1) 拮抗剂。α-NETA 微弱的抑制胆碱酯酶 (ChE; IC50=84 μM) 和乙酰胆碱酯 (AChE; IC50=300 μM)。α-NETA 具有抗癌活性。
    α-NETA
  • HY-P1844A
    Chemerin-9 (149-157) (TFA) 98.22%
    Chemerin-9 (149-157) TFA 是趋化因子样受体1 (CMKLR1) 的有效激动剂。Chemerin-9 (149-157) TFA 具有抗炎活性。Chemerin-9 (149-157) TFA 刺激 AktERK 的磷酸化以及活性氧的产生。Chemerin-9 (149-157) TFA 改善 Aβ1-42 诱导的记忆障碍。Chemerin-9 (149-157) TFA 调节免疫反应、脂肪细胞分化和糖代谢。
    Chemerin-9 (149-157) (TFA)
  • HY-126536
    ChemR23-IN-1 98.82%
    ChemR23-IN-1 是一种 ChemR23 抑制剂,对人和小鼠 ChemR23IC50 分别为 38 nM 和 100 nM。ChemR23-IN-1 在体外抑制 Chemerin 触发的 CAL-1 趋化性。
    ChemR23-IN-1
  • HY-P1844
    Chemerin-9 (149-157)
    Chemerin-9 (149-157) 是趋化因子样受体1 (CMKLR1) 的有效激动剂。Chemerin-9 (149-157) 具有抗炎活性。Chemerin-9 (149-157) 刺激 AktERK 的磷酸化以及活性氧的产生。Chemerin-9 (149-157) 改善 Aβ1-42 诱导的记忆障碍。Chemerin-9 (149-157) 调节免疫反应、脂肪细胞分化和糖代谢。
    Chemerin-9 (149-157)
  • HY-145921
    ChemR23-IN-3 Inhibitor
    ChemR23-IN-3 是一种有效的基于噻唑的 ChemR23 抑制剂,其 IC80 值为 12 nM。
    ChemR23-IN-3
  • HY-145352
    ChemR23-IN-2 Inhibitor
    ChemR23-IN-2 是一种强效且口服有效的 ChemR23 抑制剂,其 IC50 值为 3.2 nM。
    ChemR23-IN-2
  • HY-147642
    ChemR23-IN-4 Inhibitor
    ChemR23-IN-4 (Compound 13) 是一种有效的、具有口服活性的 ChemR23 抑制剂,对人 ChemR23 的 IC50 为 17 nM。
    ChemR23-IN-4
  • HY-P2712
    Chemerin-9, mouse
    Chemerin-9, mouse (Chemerin148-156, mouse) 是 Chemerin 的 C 端九肽。Chemerin-9, mouse 是 ChemR23 的配体 (EC50 = 42 nM)。Chemerin-9, mouse 可减少小鼠原代白色脂肪细胞中的基础脂肪分解 (IC50 = 3.3 nM)。Chemerin-9, mouse 增强记忆并缓解 Aβ1-42 诱导的 AD 小鼠记忆损伤。Chemerin-9, mouse 也能抑制动脉粥样硬化形成。
    Chemerin-9, mouse